Oral Spironolactone versus Conservative Treatment for Non-Resolving Central Serous Chorioretinopathy in Real-Life Practice
Author:
Publisher
Informa UK Limited
Subject
Ophthalmology
Reference38 articles.
1. Central serous chorioretinopathy: a review of epidemiology and pathophysiology
2. Central Serous Chorioretinopathy: Pathogenesis and Management
Central Serous Chorioretinopathy: Pathogenesis and Management
3. RISK FACTORS FOR CENTRAL SEROUS CHORIORETINOPATHY
4. Risk Factors for Central Serous Chorioretinopathy: Multivariate Approach in a Case-Control Study
5. FACTORS ASSOCIATED WITH REDUCED VISUAL ACUITY DURING LONG-TERM FOLLOW-UP OF PATIENTS WITH IDIOPATHIC CENTRAL SEROUS CHORIORETINOPATHY
Cited by 5 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Central serous chorioretinopathy: An evidence-based treatment guideline;Progress in Retinal and Eye Research;2024-07
2. Current and emerging treatment options for central serous chorioretinopathy;Expert Review of Ophthalmology;2024-04-10
3. Central serous chorioretinopathy: updates in the pathogenesis, diagnosis and therapeutic strategies;Eye and Vision;2023-07-11
4. Efficacy and safety of iodized lecithin tablets versus spironolactone in alleviating central serous retinopathy among Chinese patients with uncontrolled diabetes;PAK J PHARM SCI;2023
5. Using oral Rifampin to treat acute central serous Chorioretinopathy: a randomized placebo-controlled clinical trial ;Journal Of Advanced Pharmacy Education And Research;2022
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3